{"id":25614,"date":"2018-12-21T15:48:16","date_gmt":"2018-12-21T22:48:16","guid":{"rendered":"https:\/\/hepatochem.com\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\/"},"modified":"2018-12-21T15:48:16","modified_gmt":"2018-12-21T22:48:16","slug":"enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines","status":"publish","type":"post","link":"https:\/\/hepatochem.com\/euro\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\/","title":{"rendered":"Enabling synthesis in fragment-based drug discovery by reactivity mapping: photoredox-mediated cross-dehydrogenative heteroarylation of cyclic amines"},"content":{"rendered":"<p><!DOCTYPE html PUBLIC \"-\/\/W3C\/\/DTD HTML 4.0 Transitional\/\/EN\" \"http:\/\/www.w3.org\/TR\/REC-html40\/loose.dtd\"><br \/>\n<html><body><\/p>\n<div id=\"attachment_8327\" style=\"width: 310px\" class=\"wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" aria-describedby=\"caption-attachment-8327\" class=\"wp-image-8327 size-medium\" src=\"https:\/\/hepatochem.com\/wp-content\/uploads\/2020\/09\/Screen-Shot-2020-09-01-at-6.52.37-PM-300x183.png\" alt=\"\" width=\"300\" height=\"183\" srcset=\"https:\/\/hepatochem.com\/wp-content\/uploads\/2020\/09\/Screen-Shot-2020-09-01-at-6.52.37-PM-300x183.png 300w, https:\/\/hepatochem.com\/wp-content\/uploads\/2020\/09\/Screen-Shot-2020-09-01-at-6.52.37-PM.png 390w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><p id=\"caption-attachment-8327\" class=\"wp-caption-text\">The new photoredox-mediated cross-dehydrogenative method reported herein<\/p><\/div>\n<p><strong>Abstract<\/strong><\/p>\n<p>In fragment-based drug discovery (FBDD), a weakly binding fragment hit is elaborated into a potent ligand by bespoke functionalization along specific directions (growth vectors) from the fragment core in order to complement the 3D structure of the target protein. This structure-based design approach can present significant synthetic challenges, as growth vectors often originate on sp<small><sup>2<\/sup><\/small>or sp<small><sup>3<\/sup><\/small>ring carbons which are not the most synthetically accessible points on the fragment. To address this issue and expedite synthesis in FBDD, we established a nanogram-to-gram workflow for the development of enabling synthetic transformations, such as the direct C\u2013H functionalization of heterocycles. This novel approach deploys high-throughput experimentation (HTE) in 1536-well microtiter plates (MTPs) facilitated by liquid handling robots to screen reaction conditions on the nanomolar scale; subsequently the reaction is upscaled in a continuous flow to generate gram-quantities of the material. In this paper, we disclose the use of this powerful workflow for the development of a photoredox-mediated cross-dehydrogenative coupling of fragments and medicinally relevant heterocyclic precursors<span class=\"italic\">via<\/span>Minisci-type addition of \u03b1-amino radicals to electron-deficient heteroarenes. The optimized reaction conditions were employed on the milligram-scale on a diverse set of 112 substrates to map out structure\u2013reactivity relationships (SRRs) of the transformation. The coupling exhibits excellent tolerance to a variety of functional groups and N-rich heteroarenes relevant to FBDD and was upscaled in a continuous flow to afford gram-quantities of pharmaceutically relevant sp<small><sup>2<\/sup><\/small>\u2013sp<small><sup>3<\/sup><\/small>privileged architectures.<\/p>\n<p><strong>Authors:<\/strong> <span class=\"bold\">Rachel Grainger<\/span><span class=\"orcid\"><a id=\"connect-orcid-link\" title=\"Select to open ORCID record (orcid.org\/0000-0002-3944-0201) in a new window\" href=\"http:\/\/orcid.org\/0000-0002-3944-0201\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" id=\"orcid-id-logo\" src=\"https:\/\/pubs.rsc.org\/content\/NewImages\/orcid_16x16.png\" alt=\"ORCID logo\"><\/a><\/span>*<sup><span class=\"sup_ref italic\">a<\/span><\/sup>,<span class=\"bold\">Tom D. Heightman<\/span><span class=\"orcid\"><a id=\"connect-orcid-link\" title=\"Select to open ORCID record (orcid.org\/0000-0002-9109-4748) in a new window\" href=\"http:\/\/orcid.org\/0000-0002-9109-4748\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" id=\"orcid-id-logo\" src=\"https:\/\/pubs.rsc.org\/content\/NewImages\/orcid_16x16.png\" alt=\"ORCID logo\"><\/a><\/span><sup><span class=\"sup_ref italic\">a<\/span><\/sup>,<span class=\"bold\">StevenV. Ley<\/span><span class=\"orcid\"><a id=\"connect-orcid-link\" title=\"Select to open ORCID record (orcid.org\/0000-0002-7816-0042) in a new window\" href=\"http:\/\/orcid.org\/0000-0002-7816-0042\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" id=\"orcid-id-logo\" src=\"https:\/\/pubs.rsc.org\/content\/NewImages\/orcid_16x16.png\" alt=\"ORCID logo\"><\/a><\/span><sup><span class=\"sup_ref italic\">b<\/span><\/sup>,<span class=\"bold\">Fabio Lima<\/span><span class=\"orcid\"><a id=\"connect-orcid-link\" title=\"Select to open ORCID record (orcid.org\/0000-0003-2127-9568) in a new window\" href=\"http:\/\/orcid.org\/0000-0003-2127-9568\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" id=\"orcid-id-logo\" src=\"https:\/\/pubs.rsc.org\/content\/NewImages\/orcid_16x16.png\" alt=\"ORCID logo\"><\/a><\/span><sup><span class=\"sup_ref italic\">bc<\/span><\/sup><span class=\"bold\">and<\/span><span class=\"bold\">Christopher N. Johnson<\/span><span class=\"orcid\"><a id=\"connect-orcid-link\" title=\"Select to open ORCID record (orcid.org\/0000-0001-8618-9729) in a new window\" href=\"http:\/\/orcid.org\/0000-0001-8618-9729\" target=\"_blank\" rel=\"noopener noreferrer\"><img decoding=\"async\" id=\"orcid-id-logo\" src=\"https:\/\/pubs.rsc.org\/content\/NewImages\/orcid_16x16.png\" alt=\"ORCID logo\"><\/a><\/span>*<sup><span class=\"sup_ref italic\">a<\/span><\/sup><\/p>\n<p><strong>Link:<\/strong> <a href=\"https:\/\/pubs.rsc.org\/en\/content\/articlehtml\/2019\/sc\/c8sc04789h\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/pubs.rsc.org\/en\/content\/articlehtml\/2019\/sc\/c8sc04789h<\/a><\/p>\n<p><\/body><\/html><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abstract In fragment-based drug discovery (FBDD), a weakly binding fragment hit is elaborated into a potent ligand by bespoke functionalization along specific directions (growth vectors) from the fragment core in order to complement the 3D structure of the target protein. This structure-based design approach can present significant synthetic challenges, as growth vectors often originate on [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":25616,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[680],"tags":[],"class_list":["post-25614","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured-articles"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Enabling synthesis in fragment-based drug discovery by reactivity mapping: photoredox-mediated cross-dehydrogenative heteroarylation of cyclic amines<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/hepatochem.com\/euro\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/#\\\/schema\\\/person\\\/e095b8d6d9795de228233250261c2cfd\"},\"headline\":\"Enabling synthesis in fragment-based drug discovery by reactivity mapping: photoredox-mediated cross-dehydrogenative heteroarylation of cyclic amines\",\"datePublished\":\"2018-12-21T22:48:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\\\/\"},\"wordCount\":293,\"publisher\":{\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hepatochem.com\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/Screen-Shot-2020-09-01-at-6.52.37-PM.png\",\"articleSection\":[\"Featured Article\"],\"inLanguage\":\"en-EU\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\\\/\",\"url\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\\\/\",\"name\":\"Enabling synthesis in fragment-based drug discovery by reactivity mapping: photoredox-mediated cross-dehydrogenative heteroarylation of cyclic amines\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/hepatochem.com\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/Screen-Shot-2020-09-01-at-6.52.37-PM.png\",\"datePublished\":\"2018-12-21T22:48:16+00:00\",\"inLanguage\":\"en-EU\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/hepatochem.com\\\/euro\\\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-EU\",\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\\\/#primaryimage\",\"url\":\"https:\\\/\\\/hepatochem.com\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/Screen-Shot-2020-09-01-at-6.52.37-PM.png\",\"contentUrl\":\"https:\\\/\\\/hepatochem.com\\\/wp-content\\\/uploads\\\/2020\\\/09\\\/Screen-Shot-2020-09-01-at-6.52.37-PM.png\",\"width\":390,\"height\":238,\"caption\":\"A diagram of the process for dehydrogenating coupling.\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/#website\",\"url\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/\",\"name\":\"HepatoChem\",\"description\":\"Reinventing Chemistry for Life Sciences\",\"publisher\":{\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-EU\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/#organization\",\"name\":\"HepatoChem\",\"url\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-EU\",\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/xn8.6f7.myftpupload.com\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/HepatoChem-logo-lowres.png?fit=500%2C89&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/xn8.6f7.myftpupload.com\\\/wp-content\\\/uploads\\\/2019\\\/12\\\/HepatoChem-logo-lowres.png?fit=500%2C89&ssl=1\",\"width\":500,\"height\":89,\"caption\":\"HepatoChem\"},\"image\":{\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/evoluchem\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/2420256\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/#\\\/schema\\\/person\\\/e095b8d6d9795de228233250261c2cfd\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-EU\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c957a93c7d0c8dd066483ae6aed9fb20b222db3695bbe7f027a1baa409d44446?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c957a93c7d0c8dd066483ae6aed9fb20b222db3695bbe7f027a1baa409d44446?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/c957a93c7d0c8dd066483ae6aed9fb20b222db3695bbe7f027a1baa409d44446?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/hepatochem.com\\\/euro\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enabling synthesis in fragment-based drug discovery by reactivity mapping: photoredox-mediated cross-dehydrogenative heteroarylation of cyclic amines","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/hepatochem.com\/euro\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\/","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/hepatochem.com\/euro\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\/#article","isPartOf":{"@id":"https:\/\/hepatochem.com\/euro\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\/"},"author":{"name":"admin","@id":"https:\/\/hepatochem.com\/euro\/#\/schema\/person\/e095b8d6d9795de228233250261c2cfd"},"headline":"Enabling synthesis in fragment-based drug discovery by reactivity mapping: photoredox-mediated cross-dehydrogenative heteroarylation of cyclic amines","datePublished":"2018-12-21T22:48:16+00:00","mainEntityOfPage":{"@id":"https:\/\/hepatochem.com\/euro\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\/"},"wordCount":293,"publisher":{"@id":"https:\/\/hepatochem.com\/euro\/#organization"},"image":{"@id":"https:\/\/hepatochem.com\/euro\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\/#primaryimage"},"thumbnailUrl":"https:\/\/hepatochem.com\/wp-content\/uploads\/2020\/09\/Screen-Shot-2020-09-01-at-6.52.37-PM.png","articleSection":["Featured Article"],"inLanguage":"en-EU"},{"@type":"WebPage","@id":"https:\/\/hepatochem.com\/euro\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\/","url":"https:\/\/hepatochem.com\/euro\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\/","name":"Enabling synthesis in fragment-based drug discovery by reactivity mapping: photoredox-mediated cross-dehydrogenative heteroarylation of cyclic amines","isPartOf":{"@id":"https:\/\/hepatochem.com\/euro\/#website"},"primaryImageOfPage":{"@id":"https:\/\/hepatochem.com\/euro\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\/#primaryimage"},"image":{"@id":"https:\/\/hepatochem.com\/euro\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\/#primaryimage"},"thumbnailUrl":"https:\/\/hepatochem.com\/wp-content\/uploads\/2020\/09\/Screen-Shot-2020-09-01-at-6.52.37-PM.png","datePublished":"2018-12-21T22:48:16+00:00","inLanguage":"en-EU","potentialAction":[{"@type":"ReadAction","target":["https:\/\/hepatochem.com\/euro\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\/"]}]},{"@type":"ImageObject","inLanguage":"en-EU","@id":"https:\/\/hepatochem.com\/euro\/enabling-synthesis-in-fragment-based-drug-discovery-by-reactivity-mapping-photoredox-mediated-cross-dehydrogenative-heteroarylation-of-cyclic-amines\/#primaryimage","url":"https:\/\/hepatochem.com\/wp-content\/uploads\/2020\/09\/Screen-Shot-2020-09-01-at-6.52.37-PM.png","contentUrl":"https:\/\/hepatochem.com\/wp-content\/uploads\/2020\/09\/Screen-Shot-2020-09-01-at-6.52.37-PM.png","width":390,"height":238,"caption":"A diagram of the process for dehydrogenating coupling."},{"@type":"WebSite","@id":"https:\/\/hepatochem.com\/euro\/#website","url":"https:\/\/hepatochem.com\/euro\/","name":"HepatoChem","description":"Reinventing Chemistry for Life Sciences","publisher":{"@id":"https:\/\/hepatochem.com\/euro\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/hepatochem.com\/euro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-EU"},{"@type":"Organization","@id":"https:\/\/hepatochem.com\/euro\/#organization","name":"HepatoChem","url":"https:\/\/hepatochem.com\/euro\/","logo":{"@type":"ImageObject","inLanguage":"en-EU","@id":"https:\/\/hepatochem.com\/euro\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/xn8.6f7.myftpupload.com\/wp-content\/uploads\/2019\/12\/HepatoChem-logo-lowres.png?fit=500%2C89&ssl=1","contentUrl":"https:\/\/i0.wp.com\/xn8.6f7.myftpupload.com\/wp-content\/uploads\/2019\/12\/HepatoChem-logo-lowres.png?fit=500%2C89&ssl=1","width":500,"height":89,"caption":"HepatoChem"},"image":{"@id":"https:\/\/hepatochem.com\/euro\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/evoluchem","https:\/\/www.linkedin.com\/company\/2420256"]},{"@type":"Person","@id":"https:\/\/hepatochem.com\/euro\/#\/schema\/person\/e095b8d6d9795de228233250261c2cfd","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-EU","@id":"https:\/\/secure.gravatar.com\/avatar\/c957a93c7d0c8dd066483ae6aed9fb20b222db3695bbe7f027a1baa409d44446?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c957a93c7d0c8dd066483ae6aed9fb20b222db3695bbe7f027a1baa409d44446?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c957a93c7d0c8dd066483ae6aed9fb20b222db3695bbe7f027a1baa409d44446?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/hepatochem.com\/euro\/author\/admin\/"}]}},"jetpack_featured_media_url":"https:\/\/hepatochem.com\/wp-content\/uploads\/2020\/09\/Screen-Shot-2020-09-01-at-6.52.37-PM.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/hepatochem.com\/euro\/wp-json\/wp\/v2\/posts\/25614","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hepatochem.com\/euro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hepatochem.com\/euro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hepatochem.com\/euro\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hepatochem.com\/euro\/wp-json\/wp\/v2\/comments?post=25614"}],"version-history":[{"count":0,"href":"https:\/\/hepatochem.com\/euro\/wp-json\/wp\/v2\/posts\/25614\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hepatochem.com\/euro\/wp-json\/wp\/v2\/media\/25616"}],"wp:attachment":[{"href":"https:\/\/hepatochem.com\/euro\/wp-json\/wp\/v2\/media?parent=25614"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hepatochem.com\/euro\/wp-json\/wp\/v2\/categories?post=25614"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hepatochem.com\/euro\/wp-json\/wp\/v2\/tags?post=25614"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}